Panacea Index Logo

Command Palette

Search for a command to run...

Randomized controlled trial of vitamin d supplementation on toll-like receptor-2 (tlr-2) and toll-like receptor-4 (tlr-4) in tuberculosis spondylitis patients.

Journal of orthopaedic surgery and research
January 1, 1970
Jainal Arifin et al. (6 authors)
Randomized Controlled TrialJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the effect of oral vitamin D supplementation on TLR-2 and TLR-4 levels in tuberculosis spondylitis patients.

Results Summary

Vitamin D supplementation at 10,000 IU and 5,000 IU doses significantly increased vitamin D, TLR-2, and TLR-4 levels by weeks 4 and 8, while the control group showed no significant increase. The study concluded that vitamin D supplementation can enhance TLR-2 and TLR-4 levels, with 10,000 IU/day for 8 weeks raising vitamin D levels sufficiently for optimal immunomodulatory effects.

Population

Tuberculosis spondylitis patients

Effective Dosage

10,000 IU/day and 5,000 IU/day

Duration

8 weeks

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
oral supplementation with vitamin D
increase
levels of vitamin D
tuberculosis spondylitis patients
-
significant increases
#1
oral supplementation with vitamin D
increase
TLR-2 levels
tuberculosis spondylitis patients
-
significant increases
#2
oral supplementation with vitamin D
increase
TLR-4 levels
tuberculosis spondylitis patients
-
significant increases
#3
vitamin D supplements
increase
TLR-2 levels
-
-
can significantly increase
#4
vitamin D supplements
increase
TLR-4 levels
-
-
can significantly increase
#5
Supplementation with vitamin D 10,000 IU/day for 8 weeks
increase
vitamin D levels
-
> 50 ng/dl
can increase
#6
Abstract

BACKGROUND: Tuberculosis spondylitis accounts for approximately 50% of all cases of skeletal tuberculosis. Vitamin D plays a role in the immune system. Vitamin D helps in the activation of TLR-2 and TLR-4, which play a role in the process of tuberculosis infection. The objective of this study was to investigate the effect of oral supplementation with vitamin D on TLR-2 and TLR-4 levels in tuberculosis spondylitis patients. METHODS: The true Experiment Design Pretest-Posttest with Control Group (Pretest-Posttest with Control Group) was used for this research. TLR-2 and TLR-4 were measured by ELISA. Repeated ANOVA, ANOVA tests, and Kolmogorov-Smirnov normality tests on the SPSS program were used to statistically analyze the results. RESULT: In the dose groups of 10,000 IU and 5000 IU, significant increases in the levels of vitamin D, TLR-2, and TLR-4 were observed at weeks 4 and 8 (p < 0.05). In the control group, there was no significant increase. CONCLUSIONS: Vitamin D supplements can significantly increase TLR-2 and TLR-4 levels. Supplementation with vitamin D 10,000 IU/day for 8 weeks can increase vitamin D levels > 50 ng/dl to optimally act as an immunomodulator.

Medical Subject Headings (MeSH)
HumansToll-Like Receptor 2Toll-Like Receptor 4Vitamin DVitamin D DeficiencyDietary SupplementsTuberculosis, Spinal
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations1
Citations/Year0.5
Relative Citation Ratio0.28
NIH Percentile14.4%
Research Impact Scores
APT Score0.25
Weight Score1.37
Normalized Score0.69
Related Supplements
Randomized controlled trial of vitamin d supplementation on ... | Panacea Index